A New Risk-Based Scoring Approach to Individualize Prophylaxis in Patients with Hemophilia A: Results from the PREDICT Study
Doris V.K. Quon(Orthopaedic Institute for Children), Jessica Charlet(Bayer (United States)), Lisa Boggio(Indiana Hemophilia and Thrombosis Center), Robert F. Sidonio(Emory University), Janice M. Staber(University of Iowa Stead Family Children’s Hospital), Miguel Escobar(Indiana Hemophilia and Thrombosis Center), Mark T. Reding(University of Minnesota), Fernando F. Corrales-Medina(University of Miami), Akshat Jain(Loma Linda University)
Cited by 0
Related Papers
Steatosis in chronic hepatitis B: Prevalence and correlation with biochemical, histologic, viral, and metabolic parameters
|Indian Journal of Pathology and Microbiology|2011|58
Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTH
|Journal of Thrombosis and Haemostasis|2024|51
The impact of extended half‐life factor concentrates on prophylaxis for severe hemophilia in the United States
|American Journal of Hematology|2020|31